• Explore /
  • Poster
  • / Association between decline of neutrophil-to-eosinophil ratio (NER) at week 6 after ipilimumab plus nivolumab initiation and improved clinical outcomes in metastatic renal cell carcinoma (mRCC).

Association between decline of neutrophil-to-eosinophil ratio (NER) at week 6 after ipilimumab plus nivolumab initiation and improved clinical outcomes in metastatic renal cell carcinoma (mRCC).

Abstract Poster

Authors

Yu-Wei Chen

Yu-Wei Chen

Vanderbilt Ingram Cancer Center, Nashville, TN

Yu-Wei Chen , Matthew D Tucker , Landon Carter Brown , Hesham Abdallah Yasin , Kristin Kathleen Ancell , Andrew J. Armstrong , Katy Beckermann , Nancy B. Davis , Michael Roger Harrison , Elizabeth Kaiser , Renee McAlister , Kerry Schaffer , Deborah Wallace , Daniel J. George , Wendy Kimryn Rathmell , Brian I. Rini , Tian Zhang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Kidney Cancer

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 4527)

DOI

10.1200/JCO.2022.40.16_suppl.4527

Abstract #

4527

Poster Bd #

18

Abstract Disclosures

Similar Posters

First Author: Landon Carter Brown

First Author: Connor Wells

Poster

2024 ASCO Genitourinary Cancers Symposium

Combination nivolumab and ipilimumab with and without camu camu in first-line treatment of metastatic renal cell carcinoma (mRCC).

Combination nivolumab and ipilimumab with and without camu camu in first-line treatment of metastatic renal cell carcinoma (mRCC).

First Author: Regina Barragan-Carrillo

First Author: Ana-Alicia Beltran-Bless